Evaluation of new biomarkers in stage III and IV endometriosis

References

• Tomassetti C, Johnson NP, Petrozza J, International working group of AAGL, ESGE, ESHRE and WES, et al. An international terminology for endometriosis, 2021. J Minim Invasive Gynecol. 2021;28(11):1–6.
   PubMedGoogle Scholar
• de Fáveri C, Fermino PMP, Piovezan AP, et al. The inflammatory role of Pro-Resolving mediators in endometriosis: an integrative review. IJMS. 2021;22(9):4370.
   Google Scholar
• La Rosa VL, Barra F, Chiofalo B, et al. An overview on the relationship between endometriosis and infertility: the impact on sexuality and psychological well-being. J Psychosom Obstet Gynaecol. 2020;41(2):93–97.
   PubMed Web of Science ®Google Scholar
• Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256.
   PubMed Web of Science ®Google Scholar
• Coutinho LM, Ferreira MC, Rocha ALL, et al. New biomarkers in endometriosis. Adv Clin Chem. 2019;89:59–77.
   PubMed Web of Science ®Google Scholar
• Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022; Nov 14379:e070750.
   PubMedGoogle Scholar
• Kimber-Trojnar Ż, Pilszyk A, Niebrzydowska M, et al. The potential of Non-Invasive biomarkers for early diagnosis of asymptomatic patients with endometriosis. JCM. 2021;10(13):2762. Jun 23
   Google Scholar
• El Sabeh M, Afrin S, Singh B, et al. Uterine stem cells and benign gynecological disorders: role in pathobiology and therapeutic implications. Stem Cell Rev Rep. 2021;17(3):803–820. Jun
   PubMed Web of Science ®Google Scholar
• Nisenblat V, Prentice L, Bossuyt PM, et al. Combination of the non-invasive tests for the diagnosis of endometriosis. Cochrane Database Syst Rev. 2016; Jul 137(7):CD012281.
   PubMedGoogle Scholar
• Kovács Z, Glover L, Reidy F, et al. Novel diagnostic options for endometriosis - Based on the glycome and microbiome. J Adv Res. 2021; Feb 533:167–181.
   PubMed Web of Science ®Google Scholar
• Anastasiu CV, Moga MA, Elena Neculau A, et al. Biomarkers for the noninvasive diagnosis of endometriosis: state of the art and future perspectives. IJMS. 2020; Mar 421(5):1750.
   Google Scholar
• Vermeulen N, Abrao MS, Einarsson JI, International working group of AAGL, ESGE, ESHRE and WES, et al. Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification. Hum Reprod Open. 2021;2021(4):hoab025. Oct 22
   PubMedGoogle Scholar
• Sahar T, Nigam A, Anjum S, et al. Differential expression of lumican, mimecan, annexin A5 and serotransferrin in ectopic and matched eutopic endometrium in ovarian endometriosis: a case-control study. Gynecol Endocrinol. 2021;37(1):56–60. Jan
   PubMed Web of Science ®Google Scholar
• Vodolazkaia A, El-Aalamat Y, Popovic D, et al. Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis. Hum Reprod. 2012; Sep27(9):2698–2711.
   PubMed Web of Science ®Google Scholar
• Matalliotakis IM, Vassiliadis S, Goumenou AG, et al. Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment. J Reprod Immunol. 2001; Jul51(1):9–19.
   PubMed Web of Science ®Google Scholar
• Lin YJ, Lai MD, Lei HY, et al. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology. 2006; Mar147(3):1278–1286.
   PubMed Web of Science ®Google Scholar
• Mohamed ML, El Behery MM, Mansour SA. Comparative study between VEGF-A and CA-125 in diagnosis and follow-up of advanced endometriosis after conservative laparoscopic surgery. Arch Gynecol Obstet. 2013; Jan287(1):77–82.
   PubMed Web of Science ®Google Scholar
• Szubert M, Suzin J, Duechler M, et al. Evaluation of selected angiogenic and inflammatory markers in endometriosis before and after danazol treatment. Reprod Fertil Dev. 2014; Mar26(3):414–420.
   PubMed Web of Science ®Google Scholar
• Martínez S, Garrido N, Coperias JL, et al. Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum Reprod. 2007; Mar22(3):836–842.
   PubMed Web of Science ®Google Scholar
• Socolov R, Butureanu S, Angioni S, et al. The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case-control study. Eur J Obstet Gynecol Reprod Biol. 2011; Feb154(2):215–217.
   PubMed Web of Science ®Google Scholar
• Cho SH, Oh YJ, Nam A, et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. Am J Reprod Immunol. 2007; Dec58(6):497–504.
   PubMed Web of Science ®Google Scholar
• Seeber B, Sammel MD, Fan X, et al. Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril. 2008 May;89(5):1073–1081.
   PubMed Web of Science ®Google Scholar
• Kuessel L, Wenzl R, Proestling K, et al. Soluble VCAM-1/soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis. Hum Reprod. 2017; Apr 132(4):770–779.
   PubMed Web of Science ®Google Scholar
• O DF, Flores I, Waelkens E, et al. Noninvasive diagnosis of endometriosis: review of current peripheral blood and endometrial biomarkers. Best Pract Res Clin Obstet Gynaecol. 2018; Jul50:72–83.
   PubMed Web of Science ®Google Scholar
• O DF, Fassbender A, Van Bree R, et al. Technical verification and assessment of independent validation of biomarker models for endometriosis. Biomed Res Int. 2019; Jul 252019:3673060.
   PubMed Web of Science ®Google Scholar
• Hirsch M, Duffy J, Davis CJ, International Collaboration to Harmonise Outcomes and Measures for Endometriosis, et al. Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis. BJOG. 2016; Oct123(11):1761–1768.
   PubMed Web of Science ®Google Scholar